Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Oceania Healthcare (OCA.NZ)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (NZ$)	Price Target (NZ$)	Rating
2022-03-30	1.05	1.50	Buy
2022-05-09	0.99	1.55	Buy
2022-05-21	1.04	1.50	Buy
2022-07-04	0.91	1.40	Buy
2022-10-10	0.91	1.30	Buy
2022-11-23	0.79	1.20	Buy
2023-02-07	0.87	1.15	Buy
2023-05-24	0.78	1.05	Buy
2023-10-26	0.69	0.95	Buy
2024-04-15	0.61	0.90	Buy
2024-06-25	0.53	0.85	Buy
2024-09-24	0.77	0.90	Buy
2024-11-22	0.76	0.87	Buy
2025-03-05	0.67	0.90	Buy
2025-05-22	0.64	0.95	Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.